UAB "Navafarma" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Working capital requirement |
Debt-to-equity ratio |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
1,353 |
1,353 |
136 |
-136 |
-136 |
4.25 |
0.39 |
65.11 |
-10.05 |
5,752 |
2,247 |
0 |
7,999 |
2022 |
---|
4,569 |
4,479 |
2,136 |
2,136 |
2,094 |
1.73 |
0.17 |
63.62 |
46.75 |
7,888 |
1,328 |
0 |
9,216 |
2023 |
---|
0 |
0 |
-935 |
-935 |
-367 |
- |
0.23 |
- |
- |
6,953 |
1,587 |
0 |
8,540 |
Register and
explore Okredo data2023 |
---|
0 |
0 |
-935 |
-935 |
-367 |
- |
0.23 |
- |
- |
6,953 |
1,587 |
0 |
8,540 |
Register and
explore Okredo data2023
Turnover (€)
0 €-100 % *
Sales per employee (€)
0 €-100 % *
Profit before tax (€)
-935 €-144 % *
Net Profit (€)
-935 €-144 % *
Profit per employee (€)
-367 €-118 % *
Working capital requirement
-Debt-to-equity ratio
0.23 35.29 % *
Total profitability (%)
-Net profitability (%)
-Equity (€)
6,953 €-12 % *
Amounts Payable And Liabilities (€)
1,587 €20 % *
Non-current Assets (€)
0 €- *
CurrentAssets (€)
8,540 €-7 % *